Lantern Pharma Inc (LTRN) Live Share Price, Invest From India

Lantern Pharma Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

Day's High
$1.11
Day's Price Range
$2.40
$1.11
116.22%
Upside
52 Week's High
$1.11
52-Week Price Range
$5.74
$1.11
417.49%
Upside

Lantern Pharma Inc share price movements today

Previous Close: $2.09
Open: $2.25
Volume: 3.3M
Day's Low - High: $1.11 - $2.40
52 Week Low - High: $1.11 - $5.74

Lantern Pharma Inc Historical Returns

1 Month Return: -60.28 %
3 Month Return: -67.82 %
1 Year Return: -68.45 %
3 Year Return: -75.44 %
5 Year Return: -94.01 %

Lantern Pharma Inc Stock Fundamentals & Key Indicators

Check Lantern Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.4M

EPS (TTM)

-1.67

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-19.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-104.58%

Lantern Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lantern Pharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lantern Pharma Inc	BUY	$23.4M	-94.01%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.5B	132.92%	140.84	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.2B	101.77%	29.58	32.94%
Beone Medicines Ltd	NA	$31.8B	NA	112.58	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.0B	54.69%	18.25	31.41%

Stock Returns calculator for Lantern Pharma Inc Stock including INR - Dollar returns

The Lantern Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lantern Pharma Inc investment value today

Current value as on today

₹41,777

Returns

₹58,223

(-58.22%)

Returns from Lantern Pharma Inc Stock

₹68,732 (-68.73%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Lantern Pharma Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Lantern Pharma Inc. Average target price of $20

Lantern Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Lantern Pharma Inc.

What analysts predicted

94.45%UPSIDE

Target Price

$20

Current Price

$1.11

Analyzed by

8 Analysts

Target

$20.00

Lantern Pharma Inc target price $20, a slight upside of 94.45% compared to current price of $1.11. According to 8 analysts rating.

Lantern Pharma Inc Stock’s Investor Sentiment and Interest

Search interest for Lantern Pharma Inc Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 26, 2026 to March 28, 2026

Change:2% versus previous 30 day period

Lantern Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	0	-	-	-	0	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-3	-4	-5	-5	-5	-5	-4	-4	-4
EBITDA	-5	-3	-4	-5	-5	-5	-5	-4	-4	-4
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-3	-4	-5	-4	-4	-5	-4	-4	-4
Income Tax Expense	0	0	0	0	0	-	-	0	-	-
Net Income	-4	-3	-4	-5	-4	-4	-5	-4	-4	-4
Net Profit Margin	0.00%	0.00%	-1603.48%	0.00%	0.00%	0.00%	-5837.03%	-4507.31%	0.00%	0.00%

Lantern Pharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-1	-2	-5	-12	-14	-17	-22
EBITDA	-1	-2	-5	-12	-14	-15	-22
Interest Expense	-	-	-	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-1	-2	-5	-12	-14	-15	-20
Income Tax Expense	0	0	0	0	0	0	-
Net Income	-1	-2	-5	-12	-14	-15	-20
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Lantern Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-3	-4	-5	-4	-4	-5	-4	-4	-4
Operating Cash Flow	-3	-3	-3	-5	-5	-3	-4	-3	-4
Investing Cash Flow	0	0	0	0	0	3	3	3	5
Financing Cash Flow	-	0	0	-	0	-	66	-	0
Change in Cash	-3	-3	-3	-5	-4	0	-1	0	2

Lantern Pharma Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-5	-12	-14	-15	-20
Operating Cash Flow	-2	-5	-10	-12	-14	-17
Investing Cash Flow	0	0	-19	0	0	3
Financing Cash Flow	2	23	63	-2	0	0
Change in Cash	0	17	33	-14	-15	-14

Global Institutional Holdings in Lantern Pharma Inc

Funds	Holdings
Horizon Asset Management Inc/ny	0.26%
BIOS CAPITAL MANAGEMENT, LP	9.03%
Vanguard Group Inc	3.43%
Commonwealth Equity Services Inc	0.16%
Voss Capital LLC	0.45%

See all

Insights on Lantern Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 143.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 86.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, LTRN stock has moved down by -47.4%

About Lantern Pharma Inc

lantern pharma is leading a wave of innovation in cancer treatment that we believe will bring the best therapies to patients who are most likely to respond. we are pioneering precision medicine approach to cancer by tailoring promising drug programs to the right patients. our approach is to use biomarker based genetic screening to identify and treat patients that would benefit most from our drugs. we believe this approach will reduce the cost of development and increase the speed to market. our strategy is to acquire or partner with promising drug and diagnostic companies to move forward promising personalized medicine programs for cancer patients.

Organisation	Lantern Pharma Inc
Headquarters	1920 McKinney Avenue, Dallas, TX, United States, 75201
Industry	Commercial Services
CEO	Mr. Panna Sharma
E-voting on shares	Click here to vote

Key Management of Lantern Pharma Inc

Name	Title
Mr. Ernest Kitt B.S., M.S	Head of Clinical Operations
Dr. Marc C. Chamberlain M.D.	Chief Medical Officer of Starlight Therapeutics
Mr. Panna Sharma	President, CEO & Director
Mr. David R. Margrave	CFO & Secretary
Dr. Kishor Gopaldas Bhatia Ph.D.	Chief Scientific Officer & Scientific Consultant
Dr. Peter L. Nara D.V.M., M.S., Ph.D.	Co-Founder & Advisor

FAQs

What is Lantern Pharma Inc share price today?

Lantern Pharma Inc share price today is $1.11 as on March 28, 2026 at 1:29 am IST at the close of the market. Lantern Pharma Inc share today touched a day high of $2.4 and a low of $1.11.

What is the 52 week high and 52 week low for Lantern Pharma Inc share?

Lantern Pharma Inc share touched a 52 week high of $5.74 on August 6, 2025 and a 52 week low of $1.11 on March 27, 2026. Lantern Pharma Inc stock price today i.e. March 28, 2026 at 1:29 am IST is closed at $1.11,which is 80.68% down from its 52 week high and 0.00% up from its 52 week low.

What is Lantern Pharma Inc's market capitalisation today?

Lantern Pharma Inc market capitalisation is $0.00T as on March 28, 2026 at 1:29 am IST.

How to invest in Lantern Pharma Inc Stock (LTRN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lantern Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lantern Pharma Inc Shares that will get you 1.3514 shares as per Lantern Pharma Inc share price of $1.11 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Lantern Pharma Inc Stock (LTRN) from India?

Indian investors can start investing in Lantern Pharma Inc (LTRN) shares with as little as ₹94.651 or $1 (as of March 28, 2026 at 3:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Lantern Pharma Inc stock (as per the Rupee-Dollar exchange rate as on March 28, 2026 at 3:39 pm IST). Based on Lantern Pharma Inc share’s latest price of $1.11 as on March 28, 2026 at 1:29 am IST, you will get 9.0090 shares of Lantern Pharma Inc. Learn more about fractional shares .

What are the returns that Lantern Pharma Inc has given to Indian investors in the last 5 years?

Lantern Pharma Inc stock has given -94.01% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?